Prostate cancer is the second leading cause of cancer deaths among men in the United States. African- American men are disproportionately impacted by prostate cancer and exhibit the highest incidence and mortality rate in the world. The underlying reasons for significant prostate cancer health disparities in African- American men are not clearly understood and may include both biological and socio-economic factors. The RCMl program has helped Clark Atlanta University (CAU) to establish the Center for Cancer Research and Therapeutic Development (CCRTD), a premier research program in prostate cancer. CCRTD focuses on understanding prostate cancer health disparities and has successfully trained the next generation of minority scientists in the area of prostate cancer and developed a community-based educational and research program focusing on the early detection and treatment of prostate cancer. In this RCMl renewal application, we propose to enhance, improve and manage our research programs to increase efficient use of technologies, increase research capacity and competitiveness and expand our network through collaborations and partnerships with researchers, research institutes and community organizations. We propose the following specific aims to achieve our goals: 1) To recruit and support additional scientists to build a competitive basic and translational research center focused on prostate cancer health disparities and 2) To maintain and expand the existing research infrastructure within CCRTD. To achieve the specific aims, we plan to focus on two primary activities: a) Administrative Core Activity and b) Technologies and Resources for Core Laboratories Activity. Under the Administrative Core Activity, our key focus areas will be i) Collaborations and Partnerships;ii) Professional Development Activities;iii) Evaluation Plan;iv) Recruitment and Hiring of Additional Faculty Investigators/Research Staff;and v) Pilot Project Program. RCMl funding is vital for the continued development of biomedical research infrastructure at CAU in general and to assist CCRTD in expanding its focus on prostate cancer, a disease that disproportionately impacts African Americans.

Public Health Relevance

Prostate cancer affects the African-American community disproportionately. There is an increased incidence/mortality rate for African-American men however the reason for this is unknown. The Center for Cancer Research and Therapeutic Development is committed to focus on the impact of this health disparity within the African-American community.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
2G12MD007590-27A1
Application #
8742340
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Mcclure, Shelia A
Project Start
1997-06-01
Project End
2019-03-31
Budget Start
2014-05-01
Budget End
2015-03-31
Support Year
27
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Clark Atlanta University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30314
Barrett, Cachétne S X; Millena, Ana C; Khan, Shafiq A (2017) TGF-? Effects on Prostate Cancer Cell Migration and Invasion Require FosB. Prostate 77:72-81
Burton, Liza J; Dougan, Jodi; Jones, Jasmine et al. (2017) Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor. Mol Cell Biol 37:
Burton, Liza J; Henderson, Veronica; Liburd, Latiffa et al. (2017) Snail transcription factor NLS and importin ?1 regulate the subcellular localization of Cathepsin L and Cux1. Biochem Biophys Res Commun 491:59-64
Rivera, Mariela; Ramos, Yanilda; Rodríguez-Valentín, Madeline et al. (2017) Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells. PLoS One 12:e0179587
Joshi, Jugal Bharat; Patel, Divya; Morton, Derrick J et al. (2017) Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol 11:337-357
Morton, Derrick J; Patel, Divya; Joshi, Jugal et al. (2017) ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation. Oncotarget 8:2536-2549
Kong, Gui-Mei; Yu, Min; Gu, Zhongping et al. (2017) Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity. PLoS One 12:e0181601
Mohanty, Sambit K; Yagiz, Kader; Pradhan, Dinesh et al. (2017) STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer. Oncotarget 8:85997-86010
Ghotbaddini, Maryam; Cisse, Keyana; Carey, Alexis et al. (2017) Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling. PLoS One 12:e0179844
Ryans, Khamia; Omosun, Yusuf; McKeithen, Danielle N et al. (2017) The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection. BMC Immunol 18:27

Showing the most recent 10 out of 58 publications